INOVIO PHARMACEUTICALS INC's ticker is and the CUSIP is 45773H951. A total of 5 filers reported holding INOVIO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $209,000 | +52412.6% | 255,000 | 0.0% | 0.00% | – |
| Q4 2022 | $398 | -99.9% | 255,000 | 0.0% | 0.00% | – |
| Q3 2022 | $440,000 | -0.2% | 255,000 | 0.0% | 0.00% | – |
| Q2 2022 | $441,000 | -80.7% | 255,000 | +26.1% | 0.00% | – |
| Q3 2020 | $2,287,000 | -82.2% | 202,200 | -57.5% | 0.00% | -100.0% |
| Q2 2020 | $12,831,000 | +411.6% | 476,100 | +41.2% | 0.00% | +100.0% |
| Q1 2020 | $2,508,000 | – | 337,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JPMORGAN CHASE & CO | 255,000 | $441,000 | 0.00% |
| SIMPLEX TRADING, LLC | 42,200 | $73,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JANE STREET GROUP, LLC | 21,100 | $37,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 164,300 | $284,000 | 0.00% |